Dimericon Therapeutics is a startup based in Germany, most recent round Seed.
Dimericon Therapeutics is a startup based in Germany. Its most recent tracked round is Seed.
Dimericon Therapeutics is a private biotech developing crosslinked helix dimer mimetics ("Dimericons") to target hard-to-drug intracellular protein–protein interactions and to serve as templates for small-molecule development. The company is advancing a lead program toward IND-enabling preclinical studies for hematological malignancies following a Seed financing round.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.